Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Myelodysplastic Syndromes 1Leukemia, Myelomonocytic, Chronic 1Leukemia 1Bronchiolitis Obliterans Syndrome 1

Interventions

Flow Cytometry 7Blood Specimen Collection 5Surveys and Questionnaires 4Psychiatric Rehabilitation 4Polymerase Chain Reaction 4Cytogenetic Analysis 4Biopsy 4In Situ Hybridization, Fluorescence 3fludarabine 2Microarray Analysis 2Influenza Vaccines 2Immunoenzyme Techniques 2Gene Expression Profiling 2Cyclophosphamide 2Bone Marrow Transplantation 2luspatercept 1Watchful Waiting 1Vision, Ocular 1Therapeutics 1Respiratory Physiological Phenomena 1Radioimmunodetection 1Peripheral Blood Stem Cell Transplantation 1Observation 1Molecular Diagnostic Techniques 1Mesna 1Mental Status and Dementia Tests 1Melphalan 1Magnetic Resonance Spectroscopy 1Lenalidomide 1Interviews as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Myelodysplastic Syndromes × Vision, Ocular × Clear all
NCT02085798 2020-01-27

Health Outcomes of Recently Diagnosed Myelodysplastic Syndrome (MDS)/Chronic Myelomonocytic Leukemia (CMML) Patients Depending on Treatment Strategy (Wait and See, Support, Active Treatment)

Celgene

Completed
503 enrolled
MyeloidOther hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Leukemia, Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡